Post by ok2buyon Sep 01, 2020 7:56pm
141 Views
Post# 31491547
NBIO
NBIOStarting Phase 1 trial with Pritumumab (Prit.) for brain cancer. In partnership with university researchers and other clinicians as Prit. may also have an application for Covid. Insiders have tripled or even greater, the number of shares they own in the company since 2018-19. The company has recently reduced their outstanding liabilities. Just raised cash through a private equity funding. Despite all the positive news as of late, stock has moved lower on very little volume. In my opinion, at this price acquiring the stock here has been significantly derisked. Be patient on your bid, float is low and may not get your fill in one order. As always, do your own dd./ok2